Adell Harriman & Carpenter’s iShares Biotechnology ETF IBB Stock Holding History

Adell Harriman & Carpenter’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.23M	Sell	7,302 -38	-0.5%	-$6.5K	0.08%	101
2025 Q4	$1.24M	Sell	7,340 -38	-0.5%	-$6.17K	0.07%	101
2025 Q3	$1.07M	Sell	7,378 -177	-2%	-$24.2K	0.06%	101
2025 Q2	$956K	Sell	7,555 -85	-1%	-$10.4K	0.06%	101
2025 Q1	$977K	Sell	7,640 -209	-3%	-$28.3K	0.07%	99
2024 Q4	$1.04M	Sell	7,849 -192	-2%	-$27K	0.07%	98
2024 Q3	$1.17M	Sell	8,041 -157	-2%	-$22.7K	0.09%	97
2024 Q2	$1.13M	Sell	8,198 -1,718	-17%	-$229K	0.09%	94
2024 Q1	$1.36M	Sell	9,916 -125	-1%	-$17.1K	0.11%	94
2023 Q4	$1.36M	Sell	10,041 -926	-8%	-$113K	0.13%	95
2023 Q3	$1.34M	Sell	10,967 -230	-2%	-$29.2K	0.14%	91
2023 Q2	$1.42M	Sell	11,197 -603	-5%	-$78.3K	0.14%	90
2023 Q1	$1.52M	Sell	11,800 -1,378	-10%	-$180K	0.16%	90
2022 Q4	$1.73M	Sell	13,178 -635	-5%	-$82.1K	0.2%	85
2022 Q3	$1.62M	Sell	13,813 -157	-1%	-$19.5K	0.2%	88
2022 Q2	$1.64M	Sell	13,970 -775	-5%	-$92K	0.2%	82
2022 Q1	$1.92M	Sell	14,745 -3,026	-17%	-$394K	0.19%	93
2021 Q4	$2.71M	Sell	17,771 -402	-2%	-$62.2K	0.25%	84
2021 Q3	$2.94M	Sell	18,173 -1,010	-5%	-$170K	0.31%	80
2021 Q2	$3.14M	Sell	19,183 -1,271	-6%	-$196K	0.33%	80
2021 Q1	$3.08M	Sell	20,454 -785	-4%	-$125K	0.37%	73
2020 Q4	$3.22M	Sell	21,239 -1,157	-5%	-$165K	0.42%	66
2020 Q3	$3.03M	Sell	22,396 -843	-4%	-$114K	0.45%	66
2020 Q2	$3.18M	Sell	23,239 -640	-3%	-$81.6K	0.54%	58
2020 Q1	$2.57M	Sell	23,879 -2,517	-10%	-$290K	0.54%	58
2019 Q4	$3.18M	Sell	26,396 -650	-2%	-$72.5K	0.52%	63
2019 Q3	$2.69M	Sell	27,046 -3,686	-12%	-$386K	0.49%	65
2019 Q2	$3.35M	Sell	30,732 -6,463	-17%	-$687K	0.63%	54
2019 Q1	$4.16M	Sell	37,195 -3,053	-8%	-$335K	0.81%	43
2018 Q4	$3.88M	Sell	40,248 -4,158	-9%	-$441K	0.86%	42
2018 Q3	$5.41M	Sell	44,406 -527	-1%	-$62.1K	1.01%	37
2018 Q2	$4.93M	Sell	44,933 -2,605	-5%	-$279K	0.98%	36
2018 Q1	$5.07M	Buy	47,538 +2,869	+6%	+$318K	1.05%	34
2017 Q4	$4.77M	Buy	44,669 +455	+1%	+$48.6K	1.01%	35
2017 Q3	$4.92M	Buy	44,214 +570	+1%	+$60.9K	1.07%	37
2017 Q2	$4.51M	Buy	43,644 +9,759	+29%	+$961K	1.02%	39
2017 Q1	$3.31M	Sell	33,885 -1,689	-5%	-$162K	0.76%	50
2016 Q4	$3.15M	Buy	35,574 +6,774	+24%	+$617K	0.78%	49
2016 Q3	$2.78M	Sell	28,800 -147	-0.5%	-$14K	0.7%	52
2016 Q2	$2.48M	Sell	28,947 -525	-2%	-$47.1K	0.65%	53
2016 Q1	$2.56M	Sell	29,472 -6,975	-19%	-$624K	0.69%	49
2015 Q4	$4.11M	Buy	36,447 +2,550	+8%	+$277K	1.1%	37
2015 Q3	$3.43M	Buy	33,897 +201	+0.6%	+$24.1K	1.01%	42
2015 Q2	$4.14M	Sell	33,696 -828	-2%	-$99.1K	1.07%	33
2015 Q1	$3.95M	Buy	34,524 +75	+0.2%	+$8.27K	1.04%	34
2014 Q4	$3.48M	Buy	34,449 +7,740	+29%	+$752K	0.95%	40
2014 Q3	$2.29M	Hold	26,709	–	–	0.63%	57
2014 Q2	$2.29M	Sell	26,709 -1,725	-6%	-$136K	0.63%	57
2014 Q1	$2.24M	Sell	28,434 -1,965	-6%	-$164K	0.66%	53
2013 Q4	$2.3M	Sell	30,399 -1,500	-5%	-$106K	0.71%	49
2013 Q3	$2.23M	Buy	31,899 +555	+2%	+$36.4K	0.63%	44
2013 Q2	$1.82M	Buy	+31,344	New	+$1.81M	0.65%	49

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Adell Harriman & Carpenter's IBB Position: Q1 2026 in Review

Adell Harriman & Carpenter reduced its iShares Biotechnology ETF (IBB) stake by 0.52% in Q1 2026, selling an estimated $6.5K and leaving 7,302 shares worth $1.23M. The position accounts for 0.08% of the portfolio, ranked #101.

Adell Harriman & Carpenter first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.41M in Q3 2018. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Adell Harriman & Carpenter held 7,302 shares of iShares Biotechnology ETF worth $1.23M as of Q1 2026.
Adell Harriman & Carpenter sold 38 iShares Biotechnology ETF shares in Q1 2026, an estimated $6.5K.
iShares Biotechnology ETF made up 0.08% of Adell Harriman & Carpenter's portfolio in Q1 2026, its #101 holding.
Adell Harriman & Carpenter first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
Adell Harriman & Carpenter's iShares Biotechnology ETF position peaked at $5.41M in Q3 2018.
919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Adell Harriman & Carpenter's 13F filing for Q1 2026, filed 4 May 2026.